How Janssen Neuroscience is Addressing the Unmet Needs of Rare Disease Patients
is a Senior Director, Global Compound Development Team Leader for the Neuroscience Therapeutic Area at Janssen Research & Development, LLC.
21 articles
is a Senior Director, Global Compound Development Team Leader for the Neuroscience Therapeutic Area at Janssen Research & Development, LLC.
Neely Mozaffarian, M.D., Ph.D., is a Vice President and Autoantibody Pathway Area Leader for the Immunology Therapeutic Area at Janssen Research & Devel...
Laura McLinn shares her journey with her son, Jordan, who was diagnosed with a progressive rare disease called Duchenne muscular dystrophy.
Peter Emanuel, a hematologist/oncologist in Little Rock, Arkansas discusses acute hepatic porphyria (AHP), a debilitating, rare genetic disease, and a n...
Sue Washer, President and CEO of AGTC, a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthal...
Shannon Resetich, Global Franchise Head, Rare Diseases at Sanofi Genzyme discusses the company's Humanitarian Aid Program started 30 years ago.
Amy Shapiro, hematologist-oncologist and CEO and co-medical director at the Indiana Hemophilia & Thrombosis Center, Inc., discusses important treatment ...
Tiffany and Wil Cook share their experience living and coping with the diagnosis of Duchenne Muscular Dystrophy (DMD). When Will was homeschooled he t...
Hawken Miller, 23, diagnosed with Duchenne Muscular Dystrophy (DMD) at age five discusses his personal journey and how he had turned to video games as a...
Jones, a comic book artist, discusses his journey living with a myeloproliferative neoplasm, a type of rare blood cancer, that was diagnosed 10 years ag...